Showing results (11-20 of 236) with videos related to
Sort By:
Pageof 24
Respiratory Medicine and Research|February 13, 2025
Long-acting muscarinic antagonists (LAMA) in asthma: What is the best strategy?Guillaume Mahay, Maeva Zysman, Nicolas Guibert, et al.Respiratory Medicine and Research|August 31, 2023
Impact of pharmacological and non-pharmacological interventions on mortality in chronic obstructive pulmonary disease (COPD) patientsMaeva Zysman, Guillaume Mahay, Nicolas Guibert, et al.Frontiers in Physiology|August 12, 2024
Unraveling persistent dyspnea after mild COVID: insights from a case series on hyperventilation provocation testsOphélie Ritter, Sofia Noureddine, Lucie Laurent, et al.Thescientificworldjournal|July 13, 2010
Molecular circuits of resolution in airway inflammationTroy Carlo, Bruce D LevyProgress in Lipid Research|October 5, 2010
Resolvins: natural agonists for resolution of pulmonary inflammationMohib Uddin, Bruce D LevyAllergology International : Official Journal of the Japanese Society of Allergology|October 24, 2008
Chemical mediators and the resolution of airway inflammationTroy Carlo, Bruce D LevyBritish Journal of Pharmacology|July 15, 2009
Resolvins and protectins: mediating solutions to inflammationPayal Kohli, Bruce D LevyExpert Opinion on Drug Discovery|March 16, 2013
Lipoxins, resolvins and protectins: new leads for the treatment of asthmaOliver Haworth, Bruce D LevyFuture Lipidology|September 28, 2011
Uncontrolled airway inflammation in lung disease represents a defect in counter-regulatory signalingAnna Planaguma, Bruce D LevyAmerican Journal of Respiratory Cell and Molecular Biology|September 23, 2006
Lipid mediators as agonists for the resolution of acute lung inflammation and injuryCaroline Bonnans, Bruce D LevyPageof 24